世界の虚血性脳血管用溶液市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ischemic Cerebrovascular Solutions Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5218
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User	￥819,000 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、虚血性脳血管用溶液の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、外科的治療、血管内治療）、用途別市場規模（治療、実験）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・虚血性脳血管用溶液の市場動向
・企業の競争状況、市場シェア
・虚血性脳血管用溶液の種類別市場規模と予測2016-2027（投薬、外科的治療、血管内治療）
・虚血性脳血管用溶液の用途別市場規模と予測2016-2027（治療、実験）
・虚血性脳血管用溶液の北米市場規模2016-2027（アメリカ、カナダ）
・虚血性脳血管用溶液の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・虚血性脳血管用溶液のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・虚血性脳血管用溶液の中南米市場規模2016-2027（メキシコ、ブラジル）
・虚血性脳血管用溶液の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（MicroPort、Stryker Corporation、Acandis GmbH、Medicut Stent Technology、Lepu Medical Technology、Medtronic、Robocath、Capture Vascular Inc、Auris Health Inc、Stereotaxis）
・結論

Antithrombotic Therapy, Statin Therapy, And Risk Factor Modification Are The Main Treatments For Symptomatic Icad Patients. The Combined Use Of Aspirin, Damustal And Diclopidogrel Includes Aspirin And Clopidogrel, And Stents Treatment System.

Market Analysis and Insights: Global Ischemic Cerebrovascular Solutions Market
The global Ischemic Cerebrovascular Solutions market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ischemic Cerebrovascular Solutions market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ischemic Cerebrovascular Solutions market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ischemic Cerebrovascular Solutions market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ischemic Cerebrovascular Solutions market.

Global Ischemic Cerebrovascular Solutions Scope and Market Size
Ischemic Cerebrovascular Solutions market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ischemic Cerebrovascular Solutions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medication
Surgical Treatment
Endovascular Therapy

Segment by Application
Medical Treatment
Experiment

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
MicroPort
Stryker Corporation
Acandis GmbH
Medicut Stent Technology
Lepu Medical Technology
Medtronic
Robocath
Capture Vascular Inc
Auris Health Inc
Stereotaxis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ischemic Cerebrovascular Solutions Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Surgical Treatment
1.2.4 Endovascular Therapy
1.3 Market by Application
1.3.1 Global Ischemic Cerebrovascular Solutions Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Medical Treatment
1.3.3 Experiment
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ischemic Cerebrovascular Solutions Market Perspective (2016-2027)
2.2 Ischemic Cerebrovascular Solutions Growth Trends by Regions
2.2.1 Ischemic Cerebrovascular Solutions Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ischemic Cerebrovascular Solutions Historic Market Share by Regions (2016-2021)
2.2.3 Ischemic Cerebrovascular Solutions Forecasted Market Size by Regions (2022-2027)
2.3 Ischemic Cerebrovascular Solutions Industry Dynamic
2.3.1 Ischemic Cerebrovascular Solutions Market Trends
2.3.2 Ischemic Cerebrovascular Solutions Market Drivers
2.3.3 Ischemic Cerebrovascular Solutions Market Challenges
2.3.4 Ischemic Cerebrovascular Solutions Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ischemic Cerebrovascular Solutions Players by Revenue
3.1.1 Global Top Ischemic Cerebrovascular Solutions Players by Revenue (2016-2021)
3.1.2 Global Ischemic Cerebrovascular Solutions Revenue Market Share by Players (2016-2021)
3.2 Global Ischemic Cerebrovascular Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ischemic Cerebrovascular Solutions Revenue
3.4 Global Ischemic Cerebrovascular Solutions Market Concentration Ratio
3.4.1 Global Ischemic Cerebrovascular Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ischemic Cerebrovascular Solutions Revenue in 2020
3.5 Ischemic Cerebrovascular Solutions Key Players Head office and Area Served
3.6 Key Players Ischemic Cerebrovascular Solutions Product Solution and Service
3.7 Date of Enter into Ischemic Cerebrovascular Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ischemic Cerebrovascular Solutions Breakdown Data by Type
4.1 Global Ischemic Cerebrovascular Solutions Historic Market Size by Type (2016-2021)
4.2 Global Ischemic Cerebrovascular Solutions Forecasted Market Size by Type (2022-2027)

5 Ischemic Cerebrovascular Solutions Breakdown Data by Application
5.1 Global Ischemic Cerebrovascular Solutions Historic Market Size by Application (2016-2021)
5.2 Global Ischemic Cerebrovascular Solutions Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ischemic Cerebrovascular Solutions Market Size (2016-2027)
6.2 North America Ischemic Cerebrovascular Solutions Market Size by Type
6.2.1 North America Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021)
6.2.2 North America Ischemic Cerebrovascular Solutions Market Size by Type (2022-2027)
6.2.3 North America Ischemic Cerebrovascular Solutions Market Size by Type (2016-2027)
6.3 North America Ischemic Cerebrovascular Solutions Market Size by Application
6.3.1 North America Ischemic Cerebrovascular Solutions Market Size by Application (2016-2021)
6.3.2 North America Ischemic Cerebrovascular Solutions Market Size by Application (2022-2027)
6.3.3 North America Ischemic Cerebrovascular Solutions Market Size by Application (2016-2027)
6.4 North America Ischemic Cerebrovascular Solutions Market Size by Country
6.4.1 North America Ischemic Cerebrovascular Solutions Market Size by Country (2016-2021)
6.4.2 North America Ischemic Cerebrovascular Solutions Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Ischemic Cerebrovascular Solutions Market Size (2016-2027)
7.2 Europe Ischemic Cerebrovascular Solutions Market Size by Type
7.2.1 Europe Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021)
7.2.2 Europe Ischemic Cerebrovascular Solutions Market Size by Type (2022-2027)
7.2.3 Europe Ischemic Cerebrovascular Solutions Market Size by Type (2016-2027)
7.3 Europe Ischemic Cerebrovascular Solutions Market Size by Application
7.3.1 Europe Ischemic Cerebrovascular Solutions Market Size by Application (2016-2021)
7.3.2 Europe Ischemic Cerebrovascular Solutions Market Size by Application (2022-2027)
7.3.3 Europe Ischemic Cerebrovascular Solutions Market Size by Application (2016-2027)
7.4 Europe Ischemic Cerebrovascular Solutions Market Size by Country
7.4.1 Europe Ischemic Cerebrovascular Solutions Market Size by Country (2016-2021)
7.4.2 Europe Ischemic Cerebrovascular Solutions Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size (2016-2027)
8.2 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Type
8.2.1 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Type (2016-2027)
8.3 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Application
8.3.1 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Application (2016-2027)
8.4 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Region
8.4.1 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ischemic Cerebrovascular Solutions Market Size (2016-2027)
9.2 Latin America Ischemic Cerebrovascular Solutions Market Size by Type
9.2.1 Latin America Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021)
9.2.2 Latin America Ischemic Cerebrovascular Solutions Market Size by Type (2022-2027)
9.2.3 Latin America Ischemic Cerebrovascular Solutions Market Size by Type (2016-2027)
9.3 Latin America Ischemic Cerebrovascular Solutions Market Size by Application
9.3.1 Latin America Ischemic Cerebrovascular Solutions Market Size by Application (2016-2021)
9.3.2 Latin America Ischemic Cerebrovascular Solutions Market Size by Application (2022-2027)
9.3.3 Latin America Ischemic Cerebrovascular Solutions Market Size by Application (2016-2027)
9.4 Latin America Ischemic Cerebrovascular Solutions Market Size by Country
9.4.1 Latin America Ischemic Cerebrovascular Solutions Market Size by Country (2016-2021)
9.4.2 Latin America Ischemic Cerebrovascular Solutions Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size (2016-2027)
10.2 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Type
10.2.1 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Type (2016-2027)
10.3 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Application
10.3.1 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Application (2016-2027)
10.4 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Country
10.4.1 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 MicroPort
11.1.1 MicroPort Company Details
11.1.2 MicroPort Business Overview
11.1.3 MicroPort Ischemic Cerebrovascular Solutions Introduction
11.1.4 MicroPort Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021)
11.1.5 MicroPort Recent Development
11.2 Stryker Corporation
11.2.1 Stryker Corporation Company Details
11.2.2 Stryker Corporation Business Overview
11.2.3 Stryker Corporation Ischemic Cerebrovascular Solutions Introduction
11.2.4 Stryker Corporation Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021)
11.2.5 Stryker Corporation Recent Development
11.3 Acandis GmbH
11.3.1 Acandis GmbH Company Details
11.3.2 Acandis GmbH Business Overview
11.3.3 Acandis GmbH Ischemic Cerebrovascular Solutions Introduction
11.3.4 Acandis GmbH Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021)
11.3.5 Acandis GmbH Recent Development
11.4 Medicut Stent Technology
11.4.1 Medicut Stent Technology Company Details
11.4.2 Medicut Stent Technology Business Overview
11.4.3 Medicut Stent Technology Ischemic Cerebrovascular Solutions Introduction
11.4.4 Medicut Stent Technology Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021)
11.4.5 Medicut Stent Technology Recent Development
11.5 Lepu Medical Technology
11.5.1 Lepu Medical Technology Company Details
11.5.2 Lepu Medical Technology Business Overview
11.5.3 Lepu Medical Technology Ischemic Cerebrovascular Solutions Introduction
11.5.4 Lepu Medical Technology Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021)
11.5.5 Lepu Medical Technology Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Ischemic Cerebrovascular Solutions Introduction
11.6.4 Medtronic Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021)
11.6.5 Medtronic Recent Development
11.7 Robocath
11.7.1 Robocath Company Details
11.7.2 Robocath Business Overview
11.7.3 Robocath Ischemic Cerebrovascular Solutions Introduction
11.7.4 Robocath Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021)
11.7.5 Robocath Recent Development
11.8 Capture Vascular Inc
11.8.1 Capture Vascular Inc Company Details
11.8.2 Capture Vascular Inc Business Overview
11.8.3 Capture Vascular Inc Ischemic Cerebrovascular Solutions Introduction
11.8.4 Capture Vascular Inc Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021)
11.8.5 Capture Vascular Inc Recent Development
11.9 Auris Health Inc
11.9.1 Auris Health Inc Company Details
11.9.2 Auris Health Inc Business Overview
11.9.3 Auris Health Inc Ischemic Cerebrovascular Solutions Introduction
11.9.4 Auris Health Inc Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021)
11.9.5 Auris Health Inc Recent Development
11.10 Stereotaxis
11.10.1 Stereotaxis Company Details
11.10.2 Stereotaxis Business Overview
11.10.3 Stereotaxis Ischemic Cerebrovascular Solutions Introduction
11.10.4 Stereotaxis Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021)
11.10.5 Stereotaxis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ischemic Cerebrovascular Solutions Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Surgical Treatment
Table 4. Key Players of Endovascular Therapy
Table 5. Global Ischemic Cerebrovascular Solutions Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ischemic Cerebrovascular Solutions Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ischemic Cerebrovascular Solutions Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Ischemic Cerebrovascular Solutions Market Share by Regions (2016-2021)
Table 9. Global Ischemic Cerebrovascular Solutions Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Ischemic Cerebrovascular Solutions Market Share by Regions (2022-2027)
Table 11. Ischemic Cerebrovascular Solutions Market Trends
Table 12. Ischemic Cerebrovascular Solutions Market Drivers
Table 13. Ischemic Cerebrovascular Solutions Market Challenges
Table 14. Ischemic Cerebrovascular Solutions Market Restraints
Table 15. Global Ischemic Cerebrovascular Solutions Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Ischemic Cerebrovascular Solutions Market Share by Players (2016-2021)
Table 17. Global Top Ischemic Cerebrovascular Solutions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ischemic Cerebrovascular Solutions as of 2020)
Table 18. Ranking of Global Top Ischemic Cerebrovascular Solutions Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Ischemic Cerebrovascular Solutions Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ischemic Cerebrovascular Solutions Product Solution and Service
Table 22. Date of Enter into Ischemic Cerebrovascular Solutions Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Ischemic Cerebrovascular Solutions Revenue Market Share by Type (2016-2021)
Table 26. Global Ischemic Cerebrovascular Solutions Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Ischemic Cerebrovascular Solutions Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Ischemic Cerebrovascular Solutions Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Ischemic Cerebrovascular Solutions Revenue Market Share by Application (2016-2021)
Table 30. Global Ischemic Cerebrovascular Solutions Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Ischemic Cerebrovascular Solutions Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Ischemic Cerebrovascular Solutions Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Ischemic Cerebrovascular Solutions Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Ischemic Cerebrovascular Solutions Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Ischemic Cerebrovascular Solutions Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Ischemic Cerebrovascular Solutions Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Ischemic Cerebrovascular Solutions Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Ischemic Cerebrovascular Solutions Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Ischemic Cerebrovascular Solutions Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Ischemic Cerebrovascular Solutions Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Ischemic Cerebrovascular Solutions Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Ischemic Cerebrovascular Solutions Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Ischemic Cerebrovascular Solutions Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Ischemic Cerebrovascular Solutions Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Ischemic Cerebrovascular Solutions Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Ischemic Cerebrovascular Solutions Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Ischemic Cerebrovascular Solutions Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Ischemic Cerebrovascular Solutions Market Size by Country (2022-2027) & (US$ Million)
Table 62. MicroPort Company Details
Table 63. MicroPort Business Overview
Table 64. MicroPort Ischemic Cerebrovascular Solutions Product
Table 65. MicroPort Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021) & (US$ Million)
Table 66. MicroPort Recent Development
Table 67. Stryker Corporation Company Details
Table 68. Stryker Corporation Business Overview
Table 69. Stryker Corporation Ischemic Cerebrovascular Solutions Product
Table 70. Stryker Corporation Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021) & (US$ Million)
Table 71. Stryker Corporation Recent Development
Table 72. Acandis GmbH Company Details
Table 73. Acandis GmbH Business Overview
Table 74. Acandis GmbH Ischemic Cerebrovascular Solutions Product
Table 75. Acandis GmbH Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021) & (US$ Million)
Table 76. Acandis GmbH Recent Development
Table 77. Medicut Stent Technology Company Details
Table 78. Medicut Stent Technology Business Overview
Table 79. Medicut Stent Technology Ischemic Cerebrovascular Solutions Product
Table 80. Medicut Stent Technology Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021) & (US$ Million)
Table 81. Medicut Stent Technology Recent Development
Table 82. Lepu Medical Technology Company Details
Table 83. Lepu Medical Technology Business Overview
Table 84. Lepu Medical Technology Ischemic Cerebrovascular Solutions Product
Table 85. Lepu Medical Technology Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021) & (US$ Million)
Table 86. Lepu Medical Technology Recent Development
Table 87. Medtronic Company Details
Table 88. Medtronic Business Overview
Table 89. Medtronic Ischemic Cerebrovascular Solutions Product
Table 90. Medtronic Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021) & (US$ Million)
Table 91. Medtronic Recent Development
Table 92. Robocath Company Details
Table 93. Robocath Business Overview
Table 94. Robocath Ischemic Cerebrovascular Solutions Product
Table 95. Robocath Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021) & (US$ Million)
Table 96. Robocath Recent Development
Table 97. Capture Vascular Inc Company Details
Table 98. Capture Vascular Inc Business Overview
Table 99. Capture Vascular Inc Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021) & (US$ Million)
Table 100. Capture Vascular Inc Recent Development
Table 101. Auris Health Inc Company Details
Table 102. Auris Health Inc Business Overview
Table 103. Auris Health Inc Ischemic Cerebrovascular Solutions Product
Table 104. Auris Health Inc Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021) & (US$ Million)
Table 105. Auris Health Inc Recent Development
Table 106. Stereotaxis Company Details
Table 107. Stereotaxis Business Overview
Table 108. Stereotaxis Ischemic Cerebrovascular Solutions Product
Table 109. Stereotaxis Revenue in Ischemic Cerebrovascular Solutions Business (2016-2021) & (US$ Million)
Table 110. Stereotaxis Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ischemic Cerebrovascular Solutions Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Surgical Treatment Features
Figure 4. Endovascular Therapy Features
Figure 5. Global Ischemic Cerebrovascular Solutions Market Share by Application: 2020 VS 2027
Figure 6. Medical Treatment Case Studies
Figure 7. Experiment Case Studies
Figure 8. Ischemic Cerebrovascular Solutions Report Years Considered
Figure 9. Global Ischemic Cerebrovascular Solutions Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Ischemic Cerebrovascular Solutions Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Ischemic Cerebrovascular Solutions Market Share by Regions: 2020 VS 2027
Figure 12. Global Ischemic Cerebrovascular Solutions Market Share by Regions (2022-2027)
Figure 13. Global Ischemic Cerebrovascular Solutions Market Share by Players in 2020
Figure 14. Global Top Ischemic Cerebrovascular Solutions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ischemic Cerebrovascular Solutions as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Ischemic Cerebrovascular Solutions Revenue in 2020
Figure 16. Global Ischemic Cerebrovascular Solutions Revenue Market Share by Type (2016-2021)
Figure 17. Global Ischemic Cerebrovascular Solutions Revenue Market Share by Type (2022-2027)
Figure 18. North America Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Ischemic Cerebrovascular Solutions Market Share by Type (2016-2027)
Figure 20. North America Ischemic Cerebrovascular Solutions Market Share by Application (2016-2027)
Figure 21. North America Ischemic Cerebrovascular Solutions Market Share by Country (2016-2027)
Figure 22. United States Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Ischemic Cerebrovascular Solutions Market Share by Type (2016-2027)
Figure 26. Europe Ischemic Cerebrovascular Solutions Market Share by Application (2016-2027)
Figure 27. Europe Ischemic Cerebrovascular Solutions Market Share by Country (2016-2027)
Figure 28. Germany Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Ischemic Cerebrovascular Solutions Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Ischemic Cerebrovascular Solutions Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Ischemic Cerebrovascular Solutions Market Share by Region (2016-2027)
Figure 38. China Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Ischemic Cerebrovascular Solutions Market Share by Type (2016-2027)
Figure 46. Latin America Ischemic Cerebrovascular Solutions Market Share by Application (2016-2027)
Figure 47. Latin America Ischemic Cerebrovascular Solutions Market Share by Country (2016-2027)
Figure 48. Mexico Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Ischemic Cerebrovascular Solutions Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Ischemic Cerebrovascular Solutions Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Ischemic Cerebrovascular Solutions Market Share by Country (2016-2027)
Figure 54. Turkey Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Ischemic Cerebrovascular Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. MicroPort Revenue Growth Rate in Ischemic Cerebrovascular Solutions Business (2016-2021)
Figure 58. Stryker Corporation Revenue Growth Rate in Ischemic Cerebrovascular Solutions Business (2016-2021)
Figure 59. Acandis GmbH Revenue Growth Rate in Ischemic Cerebrovascular Solutions Business (2016-2021)
Figure 60. Medicut Stent Technology Revenue Growth Rate in Ischemic Cerebrovascular Solutions Business (2016-2021)
Figure 61. Lepu Medical Technology Revenue Growth Rate in Ischemic Cerebrovascular Solutions Business (2016-2021)
Figure 62. Medtronic Revenue Growth Rate in Ischemic Cerebrovascular Solutions Business (2016-2021)
Figure 63. Robocath Revenue Growth Rate in Ischemic Cerebrovascular Solutions Business (2016-2021)
Figure 64. Capture Vascular Inc Revenue Growth Rate in Ischemic Cerebrovascular Solutions Business (2016-2021)
Figure 65. Auris Health Inc Revenue Growth Rate in Ischemic Cerebrovascular Solutions Business (2016-2021)
Figure 66. Stereotaxis Revenue Growth Rate in Ischemic Cerebrovascular Solutions Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の急性虚血性脳卒中用医薬品市場規模・現状・予測（2021年-2027年）

Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5565 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、急性虚血性脳卒中用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（タブレット、カプセル、その他）、用途別市場規模（病院、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のモバイル医療ソリューション市場規模・現状・予測（2021年-2027年）

Global Mobile Medical Solutions Market Size, Status and Forecast 2021-2027
QFJ1-4509 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、モバイル医療ソリューションの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイタルサイン監視装置、ピークフローメーター、胎児モニター、マルチパラメータートラッカー）、用途別市場規模（医療、医薬品管理、...

世界の陽子線治療ソリューション市場規模・現状・予測（2021年-2027年）

Global Proton Therapy Solutions Market Size, Status and Forecast 2021-2027
QFJ1-5053 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、陽子線治療ソリューションの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シングルルーム陽子線治療ソリューション、マルチルーム陽子線治療ソリューション）、用途別市場規模（病院、陽子線治療センター、その他...

世界のカプセル内視鏡治療ソリューション市場規模・現状・予測（2021年-2027年）

Global Capsule Endoscopy Treatment Solutions Market Size, Status and Forecast 2021-2027
QFJ1-3966 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、カプセル内視鏡治療ソリューションの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療検査、ドラッグデリバリー、その他）、用途別市場規模（小腸用、胃用、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の強皮症治療市場規模・現状・予測（2021年-2027年）

Global Scleroderma Therapy Solutions Market Size, Status and Forecast 2021-2027
QFJ1-4848 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、強皮症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、抗線維化薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のLFAベース迅速試験ソリューション市場規模・現状・予測（2021年-2027年）

Global LFA-based Rapid Testing Solutions Market Size, Status and Forecast 2021-2027
QFJ1-4425 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、LFAベース迅速試験ソリューションの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（キット・試薬、テストリーダー）、用途別市場規模（医療検査、食品安全、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の経腸栄養（EN）ソリューション市場規模・現状・予測（2021年-2027年）

Global Enteral Nutrition (EN) Solutions Market Size, Status and Forecast 2021-2027
QFJ1-4189 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、経腸栄養（EN）ソリューションの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経鼻胃（NG）栄養補給、経鼻十二指腸栄養補給、経鼻空腸（NJ）栄養補給、その他）、用途別市場規模（病院、医療機関、家庭用）...

世界の移植保存溶液市場規模・現状・予測（2021年-2027年）

Global Transplantation Preservation Solutions Market Size, Status and Forecast 2021-2027
QFJ1-4975 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、移植保存溶液の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静的冷蔵、低体温灌流保存、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の全身凍結療法（WBC）市場規模・現状・予測（2021年-2027年）

Global Whole Body Cryotherapy (WBC) Solutions Market Size, Status and Forecast 2021-2027
QFJ1-5043 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、全身凍結療法（WBC）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シングルクライオジェニックチャンバーソリューション、マルチプレイヤークライオジェニックチャンバーソリューション）、用途別市場規模...

サークル急性虚血性脳卒中のグローバル市場2021

Global Circle Acute Ischemic Stroke Sales Market Report 2021
QAF27619 2021年4月21日 135Pages
本市場調査資料では、世界のサークル急性虚血性脳卒中市場について種類別（血栓溶解療法、降圧療法、抗血小板療法、抗凝固剤）、用途別（病院、外来外科センター、診断センター）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予...

世界の急性虚血性脳卒中用医薬品市場規模・現状・予測（2021年-2027年） Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important ce…
サークル急性虚血性脳卒中のグローバル市場2021 Market Analysis and Insights: Global Circle Acute Ischemic Stroke Market The global Circle Acute Ischemic Stroke market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Circle Acute Ischemic Stroke Scope and Market Size …
急性虚血性脳卒中薬のグローバル市場：規模・現状・予測2019-2025 Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important ce…
急性虚血性脳卒中薬のグローバル市場：規模・現状・予測2019-2025 Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important ce…
世界の転移性骨疾患薬物治療市場規模・現状・予測（2021年-2027年） Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. Market Analysis and Insights: Global Medication Treatment …